139 related articles for article (PubMed ID: 20130437)
21. Treatment of advanced non-small cell lung cancer.
Shepherd FA
Semin Oncol; 1994 Aug; 21(4 Suppl 7):7-18. PubMed ID: 8091244
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of the unresectable non small cell lung carcinoma].
Spásová I
Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
Danesi R; de Braud F; Fogli S; de Pas TM; Di Paolo A; Curigliano G; Del Tacca M
Pharmacol Rev; 2003 Mar; 55(1):57-103. PubMed ID: 12615954
[TBL] [Abstract][Full Text] [Related]
24. The future beyond platinum for the treatment of advanced non-small cell lung cancer.
Dragnev KH; Rigas JR
Semin Oncol; 1999 Oct; 26(5 Suppl 16):73-6. PubMed ID: 10585012
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy for lung cancer: the state of the art in 2009.
Higgins MJ; Ettinger DS
Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
[TBL] [Abstract][Full Text] [Related]
26. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy for unresectable non-small cell lung cancer.
Johnson DH
Semin Oncol; 1990 Aug; 17(4 Suppl 7):20-9. PubMed ID: 2166346
[TBL] [Abstract][Full Text] [Related]
28. Update on the role of topotecan in the treatment of non-small cell lung cancer.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():43-52. PubMed ID: 15616149
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy in metastatic and locally advanced non-small cell lung cancer.
Spigel DR; Greco FA
Semin Surg Oncol; 2003; 21(2):98-110. PubMed ID: 14508860
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
32. Overview of MTA in the treatment of non-small cell lung cancer.
Postmus PE; Green MR
Semin Oncol; 1999 Feb; 26(1 Suppl 4):31-6. PubMed ID: 10201519
[TBL] [Abstract][Full Text] [Related]
33. The role of targeted therapy in non-small cell lung cancer.
Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
[TBL] [Abstract][Full Text] [Related]
34. Management of the elderly patient with advanced non-small cell lung cancer.
Cheong KA; Chrystal K; Harper PG
Int J Clin Pract; 2006 Mar; 60(3):340-3. PubMed ID: 16494650
[TBL] [Abstract][Full Text] [Related]
35. Breakthrough test for lung cancer therapy. New test can predict whether patient will benefit from post-surgery chemotherapy.
Duke Med Health News; 2008; Suppl():7-8. PubMed ID: 18998609
[No Abstract] [Full Text] [Related]
36. Can a decisional algorithm be used in first-line treatment of advanced nonsmall cell lung cancer?
Gridelli C
Curr Opin Oncol; 2010 Mar; 22(2):77-8. PubMed ID: 20147784
[No Abstract] [Full Text] [Related]
37. [Aberrant methylation of circulating DNA for prediction of chemo-sensitivity of non-small cell lung cancer].
Takai D
Gan To Kagaku Ryoho; 2010 Feb; 37(2):189-93. PubMed ID: 20154471
[TBL] [Abstract][Full Text] [Related]
38. Personalized medicine in the treatment of advanced nonsmall cell lung cancer: step-by-step progress.
Gridelli C
Curr Opin Oncol; 2012 Mar; 24(2):115-6. PubMed ID: 22123236
[No Abstract] [Full Text] [Related]
39. [Genomic approaches to tailored therapy in non-small cell lung cancer].
Song Y
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):889-90. PubMed ID: 19134403
[No Abstract] [Full Text] [Related]
40. Clinical outcomes in non-small-cell lung cancer in relation to expression of predictive and prognostic biomarkers.
Singh N; Bal A; Aggarwal AN; Das A; Behera D
Future Oncol; 2010 May; 6(5):741-67. PubMed ID: 20465389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
